Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 147 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| CRLF2 | ENSG00000205755 | 0.00 | 0.00 | 0 | 0 |
| CRYZL1 | ENSG00000205758 | 0.00 | 0.00 | 0 | 0 |
| KLRC2 | ENSG00000205809 | 0.00 | 0.00 | 0 | 0 |
| C1QTNF9B | ENSG00000205863 | 0.00 | 0.00 | 0 | 0 |
| DEFA1 | ENSG00000206047 | 0.00 | 0.00 | 0 | 0 |
| SERPINB11 | ENSG00000206072 | 0.00 | 0.00 | 0 | 0 |
| SERPINB4 | ENSG00000206073 | 0.00 | 0.00 | 0 | 0 |
| RNASE13 | ENSG00000206150 | 0.00 | 0.00 | 0 | 0 |
| ATP10A | ENSG00000206190 | 0.00 | 0.00 | 0 | 0 |
| TSSK2 | ENSG00000206203 | 0.00 | 0.00 | 0 | 0 |
| OR10C1 | ENSG00000206474 | 0.00 | 0.00 | 0 | 0 |
| OR5K3 | ENSG00000206536 | 0.00 | 0.00 | 0 | 0 |
| PRSS50 | ENSG00000206549 | 0.00 | 0.00 | 0 | 0 |
| GPX3 | ENSG00000211445 | 0.30 | 0.00 | 1 | 0 |
| DIO2 | ENSG00000211448 | 0.00 | 0.42 | 0 | 2 |
| GNRHR2 | ENSG00000211451 | 0.28 | 0.28 | 1 | 2 |
| DIO1 | ENSG00000211452 | 0.00 | 0.00 | 0 | 0 |
| AKR7L | ENSG00000211454 | 0.00 | 0.65 | 0 | 3 |
| SLC48A1 | ENSG00000211584 | 0.00 | 0.00 | 0 | 0 |
| IGKV4-1 | ENSG00000211598 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 147 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.